BioSpace News Archive

FDA

MyoScience Inc. Receives CE Mark for Novel Cryotherapy Technology

December 8, 2011
·
1 min read
Drug Development

Zealand Pharma Announces Further Positive Results Presented by Sanofi (France) From the GetGoal Phase III Program for Lixisenatide (Lyxumia(R)1)) in Type 2 Diabetes

December 8, 2011
·
6 min read
Drug Development

BioChemics, Inc. Announces Positive Phase 2 Data for a Novel Transdermal Ibuprofen Drug Formulation Developed to Treat Osteoarthritis

December 8, 2011
·
4 min read
Pharm Country

Access Pharmaceuticals Release: MuGard Advocate Interviewed on ABC Tampa News at Noon

December 8, 2011
·
3 min read
Drug Development

Leading Investigator to Present Clinical Data on Generex Biotechnology Corporation Oral-lyn(TM) at International Diabetes Federation Meetings in Dubai

December 8, 2011
·
5 min read
BioMidwest

Biodesix, Inc. Release: VeriStrat(R) Test Predicts Outcomes in Advanced Breast Cancer Patients

December 8, 2011
·
4 min read
Genetown

Survival Benefit With Syndax Pharmaceuticals Inc.’ Entinostat Maintained in Women with Advanced Breast Cancer

December 8, 2011
·
5 min read
FDA

OraSure Technologies, Inc. Subsidiary, DNA Genotek Receives FDA 510(k) Clearance for Oragene(R) Dx Collection Device

December 8, 2011
·
4 min read
Pharm Country

Proteonomix, Inc. (PROT) Letter to Shareholders

December 8, 2011
·
4 min read
Drug Development

MorphoSys AG to Receive Milestone Payment for CNTO 1959 Phase 2 Program

December 8, 2011
·
3 min read